Vikhyat Bebarta
Concepts (630)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 37 | 2025 | 145 | 12.810 |
Why?
| | Military Personnel | 51 | 2024 | 747 | 8.610 |
Why?
| | Cyanides | 29 | 2025 | 56 | 8.280 |
Why?
| | Wounds and Injuries | 40 | 2026 | 957 | 6.580 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 33 | 6.410 |
Why?
| | Emergency Medical Services | 33 | 2025 | 696 | 5.930 |
Why?
| | Air Ambulances | 15 | 2024 | 58 | 3.940 |
Why?
| | Resuscitation | 15 | 2024 | 302 | 3.680 |
Why?
| | Swine | 40 | 2025 | 833 | 3.620 |
Why?
| | Afghan Campaign 2001- | 31 | 2024 | 195 | 3.520 |
Why?
| | Potassium Cyanide | 9 | 2025 | 22 | 3.520 |
Why?
| | Cobamides | 8 | 2022 | 25 | 3.350 |
Why?
| | Military Medicine | 16 | 2026 | 149 | 3.240 |
Why?
| | Poisoning | 10 | 2025 | 119 | 3.200 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 2.960 |
Why?
| | Intubation, Intratracheal | 12 | 2025 | 320 | 2.770 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 48 | 2.720 |
Why?
| | Infusions, Intraosseous | 10 | 2024 | 19 | 2.520 |
Why?
| | Sulfides | 8 | 2025 | 92 | 2.400 |
Why?
| | Laryngoscopes | 5 | 2025 | 45 | 2.320 |
Why?
| | Hypotension | 11 | 2021 | 126 | 2.300 |
Why?
| | Warfare | 14 | 2026 | 101 | 2.240 |
Why?
| | Critical Care | 13 | 2026 | 697 | 2.200 |
Why?
| | Apnea | 5 | 2020 | 25 | 2.130 |
Why?
| | Hospitals, Military | 9 | 2018 | 31 | 2.100 |
Why?
| | Emergency Medicine | 10 | 2018 | 261 | 2.020 |
Why?
| | Airway Management | 5 | 2019 | 79 | 1.870 |
Why?
| | Hydrocodone | 5 | 2019 | 17 | 1.850 |
Why?
| | Heart Arrest | 8 | 2024 | 407 | 1.820 |
Why?
| | Laryngoscopy | 6 | 2025 | 117 | 1.760 |
Why?
| | Emergency Service, Hospital | 18 | 2026 | 2313 | 1.760 |
Why?
| | Disease Models, Animal | 29 | 2025 | 4569 | 1.750 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 173 | 1.750 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 1143 | 1.720 |
Why?
| | Hemorrhage | 11 | 2025 | 809 | 1.650 |
Why?
| | Afghanistan | 16 | 2024 | 96 | 1.530 |
Why?
| | Analgesics | 5 | 2024 | 231 | 1.520 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 31 | 1.470 |
Why?
| | Transportation of Patients | 3 | 2018 | 68 | 1.430 |
Why?
| | Humans | 178 | 2026 | 144957 | 1.420 |
Why?
| | Ketamine | 6 | 2024 | 133 | 1.390 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 48 | 1.390 |
Why?
| | Critical Illness | 12 | 2025 | 892 | 1.380 |
Why?
| | Shock, Hemorrhagic | 6 | 2024 | 201 | 1.350 |
Why?
| | Injury Severity Score | 17 | 2026 | 600 | 1.340 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 441 | 1.280 |
Why?
| | Prospective Studies | 33 | 2026 | 7997 | 1.270 |
Why?
| | Male | 103 | 2026 | 72406 | 1.250 |
Why?
| | Female | 99 | 2026 | 78376 | 1.240 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 189 | 1.230 |
Why?
| | Airway Obstruction | 3 | 2018 | 162 | 1.210 |
Why?
| | Animals | 66 | 2025 | 38109 | 1.200 |
Why?
| | Heart Massage | 3 | 2019 | 11 | 1.180 |
Why?
| | Research | 6 | 2022 | 431 | 1.170 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 342 | 1.150 |
Why?
| | Toxicology | 4 | 2018 | 49 | 1.150 |
Why?
| | Pressure | 2 | 2020 | 225 | 1.120 |
Why?
| | Poison Control Centers | 8 | 2017 | 84 | 1.110 |
Why?
| | Adult | 72 | 2026 | 40506 | 1.110 |
Why?
| | Drug Overdose | 10 | 2016 | 370 | 1.110 |
Why?
| | Retrospective Studies | 43 | 2024 | 17101 | 1.090 |
Why?
| | Brugada Syndrome | 4 | 2008 | 14 | 1.040 |
Why?
| | Patient Transfer | 3 | 2019 | 206 | 1.030 |
Why?
| | Acute Pain | 3 | 2024 | 55 | 1.010 |
Why?
| | Registries | 19 | 2024 | 2385 | 1.010 |
Why?
| | Blood Transfusion | 8 | 2025 | 405 | 0.990 |
Why?
| | Amitriptyline | 4 | 2011 | 24 | 0.990 |
Why?
| | Oxygen Inhalation Therapy | 6 | 2026 | 182 | 0.990 |
Why?
| | Respiration, Artificial | 6 | 2023 | 708 | 0.970 |
Why?
| | Sodium Nitrite | 4 | 2016 | 39 | 0.950 |
Why?
| | Injections, Intramuscular | 8 | 2024 | 141 | 0.950 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 601 | 0.950 |
Why?
| | Pain Measurement | 3 | 2018 | 555 | 0.930 |
Why?
| | Random Allocation | 7 | 2020 | 363 | 0.930 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 47 | 0.920 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 0.910 |
Why?
| | Tandem Mass Spectrometry | 6 | 2023 | 577 | 0.890 |
Why?
| | United States | 41 | 2024 | 15988 | 0.890 |
Why?
| | Hydromorphone | 3 | 2016 | 10 | 0.880 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 72 | 0.880 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 176 | 0.880 |
Why?
| | Pain Management | 5 | 2024 | 405 | 0.860 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 106 | 0.850 |
Why?
| | Heart Ventricles | 3 | 2020 | 760 | 0.850 |
Why?
| | Hemodynamics | 11 | 2023 | 1121 | 0.850 |
Why?
| | War-Related Injuries | 3 | 2021 | 46 | 0.840 |
Why?
| | Sus scrofa | 8 | 2024 | 64 | 0.820 |
Why?
| | Balloon Occlusion | 2 | 2024 | 39 | 0.810 |
Why?
| | Snake Bites | 5 | 2019 | 24 | 0.810 |
Why?
| | Blood Pressure | 10 | 2018 | 1769 | 0.810 |
Why?
| | Freeze Drying | 1 | 2024 | 82 | 0.800 |
Why?
| | Remote Consultation | 2 | 2015 | 66 | 0.800 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 258 | 0.790 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 454 | 0.770 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.770 |
Why?
| | Plasma | 2 | 2024 | 225 | 0.760 |
Why?
| | Hypocalcemia | 4 | 2026 | 38 | 0.750 |
Why?
| | Time Factors | 15 | 2024 | 7183 | 0.750 |
Why?
| | Oxygen | 7 | 2026 | 995 | 0.750 |
Why?
| | Environmental Exposure | 4 | 2019 | 590 | 0.740 |
Why?
| | Burns | 5 | 2025 | 377 | 0.740 |
Why?
| | Trauma Centers | 7 | 2026 | 462 | 0.740 |
Why?
| | Internship and Residency | 4 | 2016 | 1257 | 0.690 |
Why?
| | Acetylcysteine | 2 | 2014 | 139 | 0.690 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.690 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 42 | 0.680 |
Why?
| | Aorta | 2 | 2024 | 430 | 0.680 |
Why?
| | Iraq | 9 | 2023 | 66 | 0.670 |
Why?
| | Administration, Intravenous | 5 | 2019 | 170 | 0.670 |
Why?
| | Pain | 5 | 2018 | 782 | 0.660 |
Why?
| | Acetaminophen | 3 | 2014 | 264 | 0.650 |
Why?
| | Epinephrine | 5 | 2022 | 155 | 0.650 |
Why?
| | Young Adult | 28 | 2021 | 14126 | 0.650 |
Why?
| | Blast Injuries | 6 | 2021 | 63 | 0.630 |
Why?
| | Thorax | 1 | 2020 | 50 | 0.630 |
Why?
| | Morphine | 3 | 2017 | 171 | 0.620 |
Why?
| | Patient Handoff | 1 | 2020 | 43 | 0.620 |
Why?
| | Thiadiazoles | 1 | 2020 | 27 | 0.620 |
Why?
| | Cannabinoids | 2 | 2012 | 182 | 0.610 |
Why?
| | Antivenins | 4 | 2013 | 29 | 0.600 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.600 |
Why?
| | Administration, Oral | 6 | 2021 | 848 | 0.600 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 423 | 0.600 |
Why?
| | Firearms | 3 | 2022 | 435 | 0.580 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 9 | 0.580 |
Why?
| | Humerus | 3 | 2022 | 39 | 0.560 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 21 | 0.550 |
Why?
| | Norepinephrine | 1 | 2019 | 196 | 0.550 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 64 | 0.550 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 15 | 0.550 |
Why?
| | Nursing Care | 1 | 2018 | 41 | 0.540 |
Why?
| | Emergency Treatment | 4 | 2018 | 124 | 0.540 |
Why?
| | Glycine | 1 | 2019 | 187 | 0.540 |
Why?
| | Military Facilities | 1 | 2017 | 4 | 0.540 |
Why?
| | Preceptorship | 1 | 2018 | 67 | 0.540 |
Why?
| | Tablets | 1 | 2017 | 41 | 0.530 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 289 | 0.530 |
Why?
| | Hyperoxia | 4 | 2023 | 99 | 0.520 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 164 | 0.520 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 4 | 0.510 |
Why?
| | Chronic Pain | 3 | 2020 | 292 | 0.510 |
Why?
| | Thiocyanates | 6 | 2024 | 28 | 0.500 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 357 | 0.500 |
Why?
| | Middle Aged | 34 | 2026 | 35928 | 0.490 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.490 |
Why?
| | Oseltamivir | 1 | 2016 | 15 | 0.490 |
Why?
| | Treatment Outcome | 17 | 2025 | 11695 | 0.490 |
Why?
| | Abdominal Pain | 2 | 2019 | 146 | 0.490 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 43 | 0.480 |
Why?
| | Tourniquets | 3 | 2021 | 34 | 0.480 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 30 | 0.480 |
Why?
| | Altitude | 1 | 2020 | 473 | 0.470 |
Why?
| | Tibia | 2 | 2014 | 176 | 0.460 |
Why?
| | Tranexamic Acid | 3 | 2023 | 53 | 0.460 |
Why?
| | Antifibrinolytic Agents | 3 | 2023 | 62 | 0.460 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 863 | 0.450 |
Why?
| | South Africa | 4 | 2024 | 261 | 0.450 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 45 | 0.440 |
Why?
| | Telemedicine | 2 | 2015 | 948 | 0.440 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 1094 | 0.440 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 124 | 0.440 |
Why?
| | Wound Infection | 2 | 2026 | 57 | 0.440 |
Why?
| | Hematinics | 1 | 2015 | 22 | 0.440 |
Why?
| | Adolescent | 25 | 2021 | 22453 | 0.430 |
Why?
| | Diphenhydramine | 2 | 2015 | 36 | 0.430 |
Why?
| | Asphyxia | 1 | 2014 | 23 | 0.430 |
Why?
| | Electrocardiography | 5 | 2012 | 663 | 0.430 |
Why?
| | Patient Simulation | 1 | 2014 | 41 | 0.420 |
Why?
| | Efficiency | 1 | 2015 | 104 | 0.420 |
Why?
| | Incidence | 11 | 2026 | 2883 | 0.410 |
Why?
| | Solvents | 2 | 2004 | 113 | 0.410 |
Why?
| | Awards and Prizes | 1 | 2015 | 71 | 0.410 |
Why?
| | Tracheotomy | 1 | 2014 | 23 | 0.410 |
Why?
| | Exsanguination | 1 | 2013 | 19 | 0.410 |
Why?
| | Self Report | 2 | 2017 | 873 | 0.410 |
Why?
| | Anemia | 1 | 2015 | 188 | 0.400 |
Why?
| | Dietary Supplements | 1 | 2017 | 576 | 0.390 |
Why?
| | Tracheostomy | 1 | 2015 | 142 | 0.390 |
Why?
| | Texas | 5 | 2017 | 278 | 0.390 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 8 | 0.380 |
Why?
| | Mobile Health Units | 2 | 2012 | 20 | 0.380 |
Why?
| | Burns, Chemical | 2 | 2017 | 32 | 0.380 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1358 | 0.380 |
Why?
| | Glyoxylates | 2 | 2023 | 8 | 0.380 |
Why?
| | Forensic Medicine | 1 | 2012 | 17 | 0.370 |
Why?
| | Aerospace Medicine | 3 | 2017 | 33 | 0.370 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 139 | 0.370 |
Why?
| | Viperidae | 2 | 2011 | 6 | 0.370 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 529 | 0.370 |
Why?
| | Methanol | 2 | 2016 | 46 | 0.370 |
Why?
| | Seizures | 3 | 2013 | 477 | 0.350 |
Why?
| | Vitamin B 12 | 1 | 2012 | 127 | 0.350 |
Why?
| | Metformin | 1 | 2015 | 319 | 0.350 |
Why?
| | Hyperalgesia | 1 | 2012 | 131 | 0.350 |
Why?
| | Fires | 1 | 2012 | 87 | 0.340 |
Why?
| | Bone and Bones | 1 | 2014 | 315 | 0.340 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 131 | 0.340 |
Why?
| | Education, Medical | 1 | 2014 | 276 | 0.340 |
Why?
| | Renal Dialysis | 1 | 2015 | 462 | 0.340 |
Why?
| | Injections, Intravenous | 5 | 2018 | 200 | 0.330 |
Why?
| | Gait | 1 | 2014 | 313 | 0.330 |
Why?
| | Fluid Therapy | 3 | 2019 | 147 | 0.330 |
Why?
| | Extremities | 2 | 2022 | 140 | 0.330 |
Why?
| | Mass Screening | 2 | 2018 | 1348 | 0.330 |
Why?
| | Waiting Lists | 1 | 2012 | 263 | 0.320 |
Why?
| | Survival Rate | 6 | 2018 | 2092 | 0.320 |
Why?
| | Blood Component Transfusion | 2 | 2024 | 103 | 0.320 |
Why?
| | Referral and Consultation | 1 | 2016 | 853 | 0.320 |
Why?
| | Hypoxia | 4 | 2026 | 1199 | 0.320 |
Why?
| | Antiviral Agents | 1 | 2016 | 768 | 0.320 |
Why?
| | Influenza, Human | 1 | 2016 | 617 | 0.320 |
Why?
| | Medical Records | 2 | 2021 | 189 | 0.310 |
Why?
| | Lung | 2 | 2020 | 4109 | 0.310 |
Why?
| | Calcium | 3 | 2026 | 1184 | 0.300 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6053 | 0.290 |
Why?
| | Survival Analysis | 4 | 2021 | 1385 | 0.290 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 11 | 0.290 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 51 | 0.280 |
Why?
| | Research Design | 5 | 2026 | 1137 | 0.280 |
Why?
| | Guideline Adherence | 4 | 2023 | 589 | 0.280 |
Why?
| | Omeprazole | 1 | 2008 | 8 | 0.280 |
Why?
| | Vascular Resistance | 3 | 2015 | 367 | 0.280 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 24 | 0.270 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 56 | 0.270 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.270 |
Why?
| | Hyponatremia | 1 | 2008 | 43 | 0.270 |
Why?
| | Coma | 2 | 2022 | 38 | 0.270 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1048 | 0.270 |
Why?
| | Scalp | 1 | 2007 | 37 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1416 | 0.260 |
Why?
| | Clinical Competence | 4 | 2026 | 1244 | 0.260 |
Why?
| | Physicians | 5 | 2019 | 940 | 0.260 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 109 | 0.260 |
Why?
| | Phosphorus | 1 | 2007 | 99 | 0.250 |
Why?
| | Limit of Detection | 4 | 2023 | 97 | 0.250 |
Why?
| | Video Recording | 2 | 2025 | 213 | 0.250 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.250 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1563 | 0.250 |
Why?
| | Methicillin Resistance | 1 | 2006 | 17 | 0.250 |
Why?
| | Linear Models | 3 | 2015 | 854 | 0.250 |
Why?
| | Formates | 1 | 2006 | 16 | 0.250 |
Why?
| | Delirium | 1 | 2008 | 104 | 0.250 |
Why?
| | Explosions | 2 | 2021 | 15 | 0.240 |
Why?
| | Poisons | 2 | 2019 | 20 | 0.240 |
Why?
| | Metabolomics | 2 | 2025 | 727 | 0.240 |
Why?
| | Models, Animal | 3 | 2024 | 392 | 0.240 |
Why?
| | Infant | 10 | 2021 | 10039 | 0.240 |
Why?
| | Blindness | 1 | 2006 | 52 | 0.240 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 7 | 0.240 |
Why?
| | Rabbits | 5 | 2021 | 648 | 0.240 |
Why?
| | Hypothermia | 2 | 2024 | 52 | 0.240 |
Why?
| | Cohort Studies | 6 | 2023 | 5965 | 0.240 |
Why?
| | Hypercalcemia | 1 | 2026 | 22 | 0.240 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 966 | 0.240 |
Why?
| | Zebrafish | 2 | 2022 | 528 | 0.230 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1389 | 0.230 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 189 | 0.230 |
Why?
| | Intention | 1 | 2007 | 183 | 0.230 |
Why?
| | Fentanyl | 2 | 2017 | 127 | 0.230 |
Why?
| | Child, Preschool | 10 | 2021 | 11799 | 0.230 |
Why?
| | Administration, Intranasal | 1 | 2025 | 93 | 0.220 |
Why?
| | Cocaine | 1 | 2007 | 161 | 0.220 |
Why?
| | Hospitals | 2 | 2022 | 732 | 0.220 |
Why?
| | Biomarkers | 4 | 2024 | 4275 | 0.220 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 77 | 0.220 |
Why?
| | Patient Care Team | 2 | 2026 | 689 | 0.220 |
Why?
| | Crotalid Venoms | 2 | 2011 | 32 | 0.220 |
Why?
| | Travel | 2 | 2016 | 136 | 0.220 |
Why?
| | Coated Materials, Biocompatible | 1 | 2025 | 65 | 0.220 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 29 | 0.220 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2025 | 57 | 0.220 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1495 | 0.220 |
Why?
| | Double-Blind Method | 2 | 2015 | 2029 | 0.210 |
Why?
| | Cannabis | 1 | 2012 | 509 | 0.210 |
Why?
| | Hydrocarbons | 1 | 2004 | 31 | 0.210 |
Why?
| | Terpenes | 1 | 2004 | 25 | 0.210 |
Why?
| | Risk | 2 | 2018 | 911 | 0.210 |
Why?
| | Feedback | 1 | 2025 | 181 | 0.210 |
Why?
| | Echocardiography | 2 | 2018 | 652 | 0.210 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 129 | 0.210 |
Why?
| | Equipment Reuse | 1 | 2024 | 18 | 0.210 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 210 | 0.210 |
Why?
| | Suicide, Attempted | 4 | 2015 | 422 | 0.210 |
Why?
| | Child | 15 | 2021 | 22657 | 0.200 |
Why?
| | Crotalus | 1 | 2004 | 24 | 0.200 |
Why?
| | Neck Injuries | 1 | 2023 | 21 | 0.200 |
Why?
| | Animal Experimentation | 1 | 2003 | 8 | 0.200 |
Why?
| | Glycolysis | 1 | 2025 | 340 | 0.200 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 62 | 0.190 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5872 | 0.190 |
Why?
| | Shock, Traumatic | 1 | 2023 | 15 | 0.190 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 120 | 0.190 |
Why?
| | Pilot Projects | 4 | 2023 | 1890 | 0.190 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 213 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2025 | 242 | 0.190 |
Why?
| | Plant Extracts | 1 | 2004 | 187 | 0.190 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 70 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2738 | 0.180 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 460 | 0.180 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 390 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Seasons | 1 | 2024 | 556 | 0.170 |
Why?
| | Toxicokinetics | 2 | 2018 | 9 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2017 | 5417 | 0.170 |
Why?
| | Soil Pollutants | 1 | 2020 | 17 | 0.170 |
Why?
| | Emergency Responders | 1 | 2021 | 37 | 0.170 |
Why?
| | Clinical Trials as Topic | 1 | 2026 | 1054 | 0.170 |
Why?
| | Lactates | 2 | 2012 | 83 | 0.170 |
Why?
| | Heart Rate | 3 | 2015 | 855 | 0.170 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 57 | 0.160 |
Why?
| | Memory | 1 | 2023 | 296 | 0.160 |
Why?
| | Disulfides | 1 | 2020 | 96 | 0.160 |
Why?
| | Guidelines as Topic | 3 | 2017 | 268 | 0.160 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 196 | 0.160 |
Why?
| | Feasibility Studies | 2 | 2023 | 1095 | 0.160 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 17 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2020 | 115 | 0.150 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 134 | 0.150 |
Why?
| | Agkistrodon | 1 | 2019 | 6 | 0.150 |
Why?
| | Wounds, Nonpenetrating | 2 | 2021 | 316 | 0.150 |
Why?
| | Thiazoles | 2 | 2024 | 136 | 0.150 |
Why?
| | Brain Injuries | 2 | 2023 | 508 | 0.150 |
Why?
| | Consensus | 2 | 2021 | 489 | 0.150 |
Why?
| | Haloperidol | 1 | 2019 | 33 | 0.150 |
Why?
| | Ketorolac | 1 | 2019 | 30 | 0.150 |
Why?
| | Endovascular Procedures | 1 | 2024 | 384 | 0.150 |
Why?
| | Brain Concussion | 2 | 2023 | 640 | 0.150 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1721 | 0.140 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 847 | 0.140 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 5 | 0.140 |
Why?
| | Gases | 1 | 2019 | 53 | 0.140 |
Why?
| | Terrorism | 1 | 2018 | 29 | 0.140 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.140 |
Why?
| | Blood Circulation | 1 | 2018 | 44 | 0.140 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 9 | 0.140 |
Why?
| | Logistic Models | 3 | 2024 | 2119 | 0.140 |
Why?
| | Tympanic Membrane Perforation | 2 | 2009 | 17 | 0.140 |
Why?
| | Documentation | 1 | 2020 | 199 | 0.140 |
Why?
| | Harm Reduction | 1 | 2019 | 51 | 0.140 |
Why?
| | Aged | 8 | 2024 | 25947 | 0.140 |
Why?
| | Torso | 1 | 2018 | 36 | 0.140 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 4 | 0.140 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 46 | 0.140 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3415 | 0.140 |
Why?
| | War Exposure | 1 | 2018 | 14 | 0.130 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.130 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.130 |
Why?
| | Analysis of Variance | 2 | 2017 | 1311 | 0.130 |
Why?
| | Tramadol | 1 | 2017 | 17 | 0.130 |
Why?
| | Saliva | 1 | 2019 | 249 | 0.130 |
Why?
| | Vascular Access Devices | 1 | 2018 | 30 | 0.130 |
Why?
| | Blood Proteins | 1 | 2019 | 249 | 0.130 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 25 | 0.130 |
Why?
| | Drug Prescriptions | 2 | 2020 | 285 | 0.130 |
Why?
| | Tidal Volume | 1 | 2018 | 111 | 0.130 |
Why?
| | Rescue Work | 1 | 2017 | 12 | 0.130 |
Why?
| | Acidosis | 2 | 2009 | 105 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 427 | 0.130 |
Why?
| | Disease Management | 3 | 2017 | 647 | 0.130 |
Why?
| | Dextromethorphan | 1 | 2016 | 24 | 0.120 |
Why?
| | Cognition | 1 | 2025 | 1269 | 0.120 |
Why?
| | Shock, Septic | 1 | 2019 | 216 | 0.120 |
Why?
| | Hemoglobins | 2 | 2018 | 384 | 0.120 |
Why?
| | Blood Coagulation | 1 | 2018 | 268 | 0.120 |
Why?
| | Antacids | 1 | 2016 | 16 | 0.120 |
Why?
| | Sodium Chloride | 1 | 2017 | 142 | 0.120 |
Why?
| | Headache | 1 | 2017 | 150 | 0.120 |
Why?
| | Telephone | 1 | 2017 | 175 | 0.120 |
Why?
| | Epidemics | 1 | 2018 | 98 | 0.120 |
Why?
| | Educational Status | 2 | 2016 | 467 | 0.120 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 428 | 0.120 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 90 | 0.120 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1268 | 0.120 |
Why?
| | Medical Errors | 1 | 2017 | 118 | 0.120 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 81 | 0.120 |
Why?
| | Decision Trees | 1 | 2016 | 81 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2018 | 282 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 338 | 0.120 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 35 | 0.120 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 105 | 0.120 |
Why?
| | Inpatients | 1 | 2020 | 546 | 0.120 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 13 | 0.120 |
Why?
| | Heart Diseases | 1 | 2019 | 350 | 0.120 |
Why?
| | Algorithms | 2 | 2016 | 1839 | 0.120 |
Why?
| | Massachusetts | 1 | 2016 | 180 | 0.120 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 216 | 0.110 |
Why?
| | Radiation Injuries | 1 | 2017 | 151 | 0.110 |
Why?
| | Sepsis | 1 | 2021 | 641 | 0.110 |
Why?
| | Prognosis | 2 | 2019 | 4293 | 0.110 |
Why?
| | Methotrexate | 1 | 2016 | 240 | 0.110 |
Why?
| | Drug Utilization Review | 1 | 2015 | 61 | 0.110 |
Why?
| | Disaster Planning | 1 | 2016 | 102 | 0.110 |
Why?
| | Benzodiazepines | 1 | 2016 | 168 | 0.110 |
Why?
| | Angiography | 2 | 2013 | 208 | 0.110 |
Why?
| | Drug Costs | 1 | 2016 | 116 | 0.110 |
Why?
| | Equipment Design | 2 | 2024 | 530 | 0.110 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 311 | 0.110 |
Why?
| | Phenols | 1 | 2015 | 114 | 0.110 |
Why?
| | Proteome | 1 | 2019 | 518 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1325 | 0.110 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1915 | 0.110 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2456 | 0.110 |
Why?
| | Metabolome | 1 | 2018 | 384 | 0.110 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 20 | 0.110 |
Why?
| | Vitamin B Complex | 1 | 2014 | 40 | 0.110 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 3 | 0.100 |
Why?
| | Health Services Research | 1 | 2016 | 396 | 0.100 |
Why?
| | Shock | 2 | 2012 | 108 | 0.100 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 85 | 0.100 |
Why?
| | Nurses | 1 | 2016 | 178 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2014 | 106 | 0.100 |
Why?
| | Teaching Rounds | 1 | 2015 | 74 | 0.100 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 257 | 0.100 |
Why?
| | Alanine Transaminase | 1 | 2014 | 151 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 887 | 0.100 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 23 | 0.100 |
Why?
| | Mortality | 1 | 2016 | 376 | 0.100 |
Why?
| | Ischemia | 2 | 2014 | 421 | 0.100 |
Why?
| | Mentors | 1 | 2015 | 219 | 0.100 |
Why?
| | Length of Stay | 2 | 2016 | 1337 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2014 | 118 | 0.100 |
Why?
| | Necrosis | 1 | 2014 | 244 | 0.100 |
Why?
| | Anesthetics | 1 | 2014 | 99 | 0.100 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 185 | 0.100 |
Why?
| | Academic Medical Centers | 1 | 2016 | 548 | 0.100 |
Why?
| | Health Surveys | 1 | 2015 | 518 | 0.100 |
Why?
| | Oximetry | 2 | 2026 | 126 | 0.090 |
Why?
| | Aged, 80 and over | 3 | 2016 | 8279 | 0.090 |
Why?
| | Data Collection | 1 | 2015 | 635 | 0.090 |
Why?
| | Drug Combinations | 1 | 2014 | 392 | 0.090 |
Why?
| | Drug Stability | 1 | 2013 | 164 | 0.090 |
Why?
| | Common Cold | 1 | 2012 | 15 | 0.090 |
Why?
| | Proteomics | 1 | 2019 | 1195 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2032 | 0.090 |
Why?
| | Respiratory System Agents | 1 | 2012 | 23 | 0.090 |
Why?
| | Multicenter Studies as Topic | 2 | 2026 | 405 | 0.090 |
Why?
| | Cadaver | 2 | 2024 | 304 | 0.090 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 27 | 0.090 |
Why?
| | Nitriles | 1 | 2013 | 205 | 0.090 |
Why?
| | Basilar Artery | 1 | 2012 | 7 | 0.090 |
Why?
| | Cues | 1 | 2014 | 326 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 109 | 0.090 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 65 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2023 | 598 | 0.090 |
Why?
| | Safety | 2 | 2013 | 356 | 0.090 |
Why?
| | Fever | 1 | 2013 | 312 | 0.090 |
Why?
| | Cough | 1 | 2012 | 124 | 0.090 |
Why?
| | Burn Units | 2 | 2025 | 48 | 0.090 |
Why?
| | Triage | 2 | 2017 | 249 | 0.090 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 90 | 0.080 |
Why?
| | Risk Assessment | 2 | 2018 | 3676 | 0.080 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 27 | 0.080 |
Why?
| | Femur | 1 | 2013 | 250 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2012 | 539 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 561 | 0.080 |
Why?
| | Drug Administration Routes | 1 | 2010 | 44 | 0.080 |
Why?
| | Needlestick Injuries | 1 | 2010 | 3 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2015 | 705 | 0.080 |
Why?
| | Sleep Stages | 1 | 2010 | 75 | 0.080 |
Why?
| | Nausea | 1 | 2010 | 111 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 244 | 0.080 |
Why?
| | Mice | 4 | 2023 | 18365 | 0.080 |
Why?
| | Vomiting | 1 | 2010 | 130 | 0.080 |
Why?
| | Manikins | 1 | 2009 | 35 | 0.070 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 292 | 0.070 |
Why?
| | Anaphylaxis | 1 | 2010 | 102 | 0.070 |
Why?
| | Intensive Care Units | 2 | 2025 | 916 | 0.070 |
Why?
| | Allied Health Personnel | 1 | 2009 | 55 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 893 | 0.070 |
Why?
| | Curriculum | 1 | 2015 | 1060 | 0.070 |
Why?
| | Mental Health | 1 | 2015 | 792 | 0.070 |
Why?
| | Inservice Training | 1 | 2009 | 117 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1990 | 0.070 |
Why?
| | Thoracostomy | 1 | 2007 | 18 | 0.070 |
Why?
| | Dermis | 1 | 2007 | 32 | 0.070 |
Why?
| | Unconsciousness | 1 | 2007 | 22 | 0.070 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 361 | 0.060 |
Why?
| | Spectrum Analysis | 2 | 2018 | 93 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2015 | 1177 | 0.060 |
Why?
| | Primary Health Care | 2 | 2020 | 1734 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2007 | 307 | 0.060 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 265 | 0.060 |
Why?
| | Risk Factors | 5 | 2017 | 10792 | 0.060 |
Why?
| | Sodium Channels | 1 | 2007 | 63 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2011 | 456 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2925 | 0.060 |
Why?
| | Ukraine | 1 | 2026 | 35 | 0.060 |
Why?
| | Vasopressins | 1 | 2006 | 60 | 0.060 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 8 | 0.060 |
Why?
| | Propylamines | 1 | 2005 | 11 | 0.060 |
Why?
| | Death, Sudden | 1 | 2005 | 24 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 144 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2019 | 724 | 0.060 |
Why?
| | Valproic Acid | 1 | 2005 | 48 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 365 | 0.060 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 124 | 0.060 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 19 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 575 | 0.060 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 71 | 0.050 |
Why?
| | Task Performance and Analysis | 1 | 2026 | 198 | 0.050 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.050 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.050 |
Why?
| | Hexanones | 1 | 2004 | 2 | 0.050 |
Why?
| | Hexanes | 1 | 2004 | 4 | 0.050 |
Why?
| | Cyclohexenes | 1 | 2004 | 5 | 0.050 |
Why?
| | Alkanes | 1 | 2004 | 14 | 0.050 |
Why?
| | Forensic Toxicology | 1 | 2024 | 2 | 0.050 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 41 | 0.050 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 174 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 44 | 0.050 |
Why?
| | Oleic Acid | 1 | 2004 | 42 | 0.050 |
Why?
| | Electric Power Supplies | 1 | 2024 | 52 | 0.050 |
Why?
| | Catheters | 1 | 2024 | 75 | 0.050 |
Why?
| | Charcoal | 1 | 2004 | 27 | 0.050 |
Why?
| | Sorbitol | 1 | 2023 | 13 | 0.050 |
Why?
| | Blood Cell Count | 1 | 2004 | 54 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2026 | 372 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2012 | 1099 | 0.050 |
Why?
| | Simulation Training | 1 | 2026 | 134 | 0.050 |
Why?
| | Half-Life | 2 | 2014 | 151 | 0.050 |
Why?
| | Masks | 1 | 2024 | 70 | 0.050 |
Why?
| | Parents | 1 | 2012 | 1403 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2004 | 70 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2005 | 242 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5614 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 91 | 0.050 |
Why?
| | Observer Variation | 1 | 2004 | 355 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 53 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 601 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2023 | 53 | 0.050 |
Why?
| | Fibrinogen | 1 | 2004 | 177 | 0.050 |
Why?
| | Biofilms | 1 | 2025 | 278 | 0.050 |
Why?
| | Specimen Handling | 1 | 2024 | 186 | 0.050 |
Why?
| | Hemostasis | 1 | 2023 | 102 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 387 | 0.050 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 100 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 174 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2022 | 55 | 0.040 |
Why?
| | Armed Conflicts | 1 | 2021 | 15 | 0.040 |
Why?
| | Bandages | 1 | 2021 | 42 | 0.040 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 189 | 0.040 |
Why?
| | Cricetulus | 1 | 2021 | 118 | 0.040 |
Why?
| | Aviation | 1 | 2021 | 10 | 0.040 |
Why?
| | CHO Cells | 1 | 2021 | 171 | 0.040 |
Why?
| | Hypertension | 1 | 2010 | 1264 | 0.040 |
Why?
| | Fumigation | 1 | 2020 | 3 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 304 | 0.040 |
Why?
| | Sheep | 1 | 2004 | 880 | 0.040 |
Why?
| | Hydrazines | 1 | 2021 | 37 | 0.040 |
Why?
| | Temperature | 1 | 2024 | 679 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2540 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3335 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2025 | 1031 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 63 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 293 | 0.040 |
Why?
| | Hemolysis | 1 | 2022 | 243 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 62 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1209 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 1003 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 179 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 44 | 0.040 |
Why?
| | Quality Improvement | 2 | 2021 | 1291 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1733 | 0.040 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.030 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 1 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 62 | 0.030 |
Why?
| | North America | 1 | 2019 | 310 | 0.030 |
Why?
| | Drug Storage | 1 | 2018 | 53 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1540 | 0.030 |
Why?
| | Resource Allocation | 1 | 2018 | 53 | 0.030 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 119 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2021 | 6434 | 0.030 |
Why?
| | Hippocampus | 1 | 2023 | 967 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 998 | 0.030 |
Why?
| | Hospitalization | 2 | 2019 | 2434 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 214 | 0.030 |
Why?
| | Multiple Trauma | 1 | 2018 | 116 | 0.030 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 104 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2018 | 242 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 768 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 102 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 230 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 780 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 183 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1087 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 9 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 710 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2118 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 164 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 91 | 0.030 |
Why?
| | Neurons | 1 | 2023 | 1642 | 0.030 |
Why?
| | Eating | 1 | 2016 | 392 | 0.030 |
Why?
| | Thiazolidines | 1 | 2013 | 13 | 0.030 |
Why?
| | Pharmacokinetics | 1 | 2013 | 32 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2013 | 106 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2013 | 39 | 0.020 |
Why?
| | Species Specificity | 1 | 2014 | 574 | 0.020 |
Why?
| | Teaching | 1 | 2015 | 236 | 0.020 |
Why?
| | Traumatology | 1 | 2012 | 35 | 0.020 |
Why?
| | Quality Control | 1 | 2012 | 163 | 0.020 |
Why?
| | Critical Care Nursing | 1 | 2013 | 51 | 0.020 |
Why?
| | Qualitative Research | 1 | 2020 | 1671 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1327 | 0.020 |
Why?
| | Organizational Innovation | 1 | 2012 | 120 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 61 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 262 | 0.020 |
Why?
| | Educational Measurement | 1 | 2015 | 326 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 136 | 0.020 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 205 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3608 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 293 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2014 | 395 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 757 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 8 | 0.020 |
Why?
| | Injections | 1 | 2010 | 197 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 107 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 331 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2880 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 393 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1660 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 331 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 27 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 109 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 136 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2007 | 249 | 0.010 |
Why?
| | Electric Countershock | 1 | 2006 | 127 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2012 | 947 | 0.010 |
Why?
| | Haplorhini | 1 | 2005 | 52 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 2920 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3869 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|